Sfoglia per AUTORE
SILLETTA M
Collezione AOU Novara
Items : 2
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis. in Cancers / Cancers (Basel). 2023 Jan 6;15(2):381. doi: 10.3390/cancers15020381.
2023
AOU Novara
AOU Novara
Giacomelli L; Papa S; Giordano G; Dadduzio V; Gadaleta-Caldarola G; Paolillo R; Giannini EG; Pieri G; Mega A; Granito A; Marzi L; Masi G; Cesario S; Rancatore G; Cabibbo G; Cocuzza C; Russello M; Gallo P; Silletta M; Daniele B; Federico P; Pirisi M; Burlone ME; di Costanzo GG; Tortora R; Ramai D; Sacco R; Renzulli M; Maida M; et alii...
Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis. in ESMO open / ESMO Open. 2022 Dec;7(6):100591. doi: 10.1016/j.esmoop.2022.100591. Epub 2022 Oct 6.
2022
AOU Novara
AOU Novara
Rimini M; Rimassa L; Ueshima K; Burgio V; Shigeo S; Tada T; Suda G; Yoo C; Cheon J; Pinato DJ; Lonardi S; Scartozzi M; Iavarone M; Di Costanzo GG; Marra F; Soldà C; Tamburini E; Piscaglia F; Masi G; Cabibbo G; Foschi FG; Silletta M; Pressiani T; Nishida N; Iwamoto H; Sakamoto N; Ryoo BY; Chon HJ; Claudia F; et alii...